期刊文献+

三氧化二砷对人骨髓瘤细胞株U266作用的研究

Effect of arsenic trioxide on myeloma U266 cells
暂未订购
导出
摘要 目的研究三氧化二砷(As2O3)对多发性骨髓瘤细胞株U266的作用。方法应用不同浓度的As2O3处理U266,采用细胞培养、流式细胞测定、原位杂交和酶联免疫吸附测定技术检测As2O3对U266的细胞活力、细胞凋亡、癌基因bcl-2表达和血管内皮细胞生长因子(VEGF)分泌的影响。结果As2O3可抑制U266的细胞活力,诱导细胞凋亡,抑制细胞bcl-2表达和VEGF的合成,VEGF可部分阻断As2O3的作用。结论As2O3可以通过多种机制发挥抗肿瘤作用。 Objective To investigate the effect of arsenic trioxide on multiple myeloma U266 cell line. Methods U266 cells were cultured with different concentrations of As2O3, and the effect of As2O3 on the vigor, apoptosis, expression of bcl-2, secretion of VEGF of U266 cells were detected by flow cytometry, situ hybridization, enzyme-linked immunosorbent assay. Results As2O3 could decrease the vigor, expression of bcl-2 and secretion of vascular endothelial cell growth factor (VEGF), and could induce apoptosis of U266 cells in dosage-dependent and time-dependent manners, and VEGF could partly block the effect of As2O3. Conclusion As2O3 can play antitumour role in multiple mechanisms.
出处 《河北医药》 CAS 2009年第2期141-142,共2页 Hebei Medical Journal
基金 河北省科技攻关计划项目(编号:062761333)
关键词 三氧化二砷 骨髓瘤细胞株U266 BCL-2 细胞凋亡 血管内皮细胞生长因子 arsenic trioxide myeloma U266 cell line bcl-2 apeptosis vascular endothelial cell growth factor
  • 相关文献

参考文献10

  • 1Bonati A, Rizzoli V,Lunghi P. Arsenic trioxide in hematological malignancies:the new discovery of an ancient drug. Curr Pharm Biotechnol, 2006,7: 397-405.
  • 2Petters.son HM, Karlsson J, Pietras A, et al. Arsenic trioxide and neuroblastoma eytotoxicity. J Bioenerg Biomembr, 2007,39: 35-41.
  • 3Gazitt Y, Akay C. Arsenic trioxide: an anti cancer missile with multiple warheads. Hematology, 2005,10: 205-213.
  • 4Engel RH, Evens AM. Oxidative stress and apoptosis: a new treatment paradigm in cancer. Front Biosci, 2006, 11 : 300-312.
  • 5孟建波,王金铠,张金巧,康素娴,杨彦.三氧化二砷对人脐静脉内皮细胞作用的研究[J].河北医药,2008,30(3):288-290. 被引量:4
  • 6Podar K, Richardson PG, Chauhan D, et al. Targeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma. Expert Rev Anticancer Ther, 2007,7 : 551-566.
  • 7Orpana A, Salven P. Angiogenic and lymphangiogenic molecules in hematological malignancies. Leuk Lymphoma, 2002,43 : 219-224.
  • 8孟建波,王金铠,张金巧,王俊祥,常英军.多发性骨髓瘤血管内皮细胞生长因子表达的临床意义[J].临床荟萃,2004,19(15):867-868. 被引量:3
  • 9O' Cormor KC, Muhitch JW, Lacks DJ, et al. Modeling suppression of cell death by Bcl-2 over-expression in myeloma NS0 6AI cells. Biotechnol Lett, 2006,28:1919-1924.
  • 10Chen Q, Ray S, Hussein MA, et al. Role of Apo2L/TRAIL and Bel-2-family proteins in apoptosis of multiple myeloma. Leuk Lymphoma,2003,44:1209- 1214.

二级参考文献9

  • 1孟建波,王金铠,张金巧,王俊祥,常英军.多发性骨髓瘤血管内皮细胞生长因子表达的临床意义[J].临床荟萃,2004,19(15):867-868. 被引量:3
  • 2Yan-Feng Xiao,Shan-Xi Liu,De-Dong Wu,Xi Chen,Li-Fen Ren.Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer[J].World Journal of Gastroenterology,2006,12(36):5780-5786. 被引量:47
  • 3[2]CARMELIET P.Mechanism of angiogenesis and arteriogenesis[J].Nat Med,2000,6(4):389-395.
  • 4[3]de BONT E S,NEEFJES V M E,ROSATI S,et al.New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia:does it matter? [J].Leuke Lymph,2002,43(10):1901-1909.
  • 5[4]DANKBAR B,PADRO T,LEO R,et al.Vascular endothelial cell growth factor and interleukin-6 in paracrine tumor-stromal cell interaction in multiple myeloma[J].Blood,2000,95(8):2630-2636.
  • 6[5]GUPTA D,TRESON S P,SHIMA Y,et al.Adherence of multiple myeloma cells upragulats vascular endothelial growth factor secretion: therapeutic application[J].Leukemia,2001,15(12): 1950-1961.
  • 7[6]ODAR K,TAI Y,DARIES F E,et al.Vascular endothelial cell growth factor triggers signaling cascades mediating multiple myloma cell growth and migration[J].Blood,2001,98(2):428-435.
  • 8[7]IWASAKI T,HAMANO T,OGATA A,et al.Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma[J].Br J Haematol,2002,116(4):796-802.
  • 9[8]SEZER O,JAKOB C,EUCKER J,et al.Serum levels of the angiogenic cytokines basic fibroblast growth factor(bFGF),vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma[J].Eur J Haematol,2001,66(2):83-88.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部